AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-23.26%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$75.7M
AUM Growth
+$75.7M
(-13%)
Cap. Flow
+$10.8M
Cap. Flow
% of AUM
14.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
Annexon
ANNX
|
$10.2M |
| 2 |
Akebia Therapeutics
AKBA
|
$625K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Annexon
ANNX
$226M
| $27.2M | 35.9% | 7,056,024 +2,647,058 | +60% | +$10.2M |
|
2
American Well
AMWL
$111M
| $24.7M | 32.67% | 10,475,717 | – | – |
|
|
WHWK
3
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| $11.8M | 15.6% | 1,630,830 | – | – |
|
|
4
Akebia Therapeutics
AKBA
$833M
| $9.08M | 12% | 16,205,119 +1,115,000 | +7% | +$625K |
|
5
Assembly Biosciences
ASMB
$190M
| $1.87M | 2.47% | 2,227,500 | – | – |
|
|
RNTX
6
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $1.03M | 1.36% | 830,466 | – | – |
|